secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2026-08-05T20:07:40+00:00
Accession:  0001801170-26-000196
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health Q2 2026 GAAP net income $28M, revenue up 56% YoY, raises full-year guidance
--------------------------------------------------------------------------------

- Q2 GAAP net income $28M vs loss $10.6M YoY; revenue $743M (+56%).
- Medicare Advantage membership 157,309 (+48% YoY); Insurance BER 87.6% (improved 80 bps).
- Adjusted EBITDA $40.9M (+139% YoY); Adjusted net income $40.4M.
- Raised FY 2026 guidance: revenue $2.92B-$3.00B, GAAP net income $20M-$35M, Adjusted EBITDA $70M-$85M.
- CEO cites AI-powered Clover Assistant platform driving growth and profitability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000196/0001801170-26-000196-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000196/clov-20260805.htm
  HTML page:      https://secwatch.observer/filing/0001801170-26-000196

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer